Vol.

No.

February 19, 2021Feb 19, 2021

DOWNLOAD THE PDF

Cover Story

Moffitt Cancer Center: Why we are building the first machine learning department in oncology

Imagine a future where cancer patients are able to receive the treatment they precisely need and not the treatment that is prescribed to all.

Conversation with The Cancer Letter COVID-19 & Cancer

Antoni Ribas: Cancer research has been pivotal to development of COVID-19 vaccines

By Alexandria Carolan

Conversation with The Cancer Letter

Lori Pierce: Therapies are of no use when patients can't get off work to be treated

By Robert A. Winn

Black History Month Free Guest Editorial

Remembering Jane Cooke Wright, a Black woman physician, who was among seven founders of ASCO

By Edith P. Mitchell

Free In the Archives

Presidents Day, Black History Month, Lasker Awards

Clinical Free Trials & Tribulations

City of Hope leads Cancer Patients Bill of Rights resolution, aimed at expanding access to unleash the full benefits of cancer care innovation

By Harlan Levine and Joseph Alvarnas

In Brief

Richard Nixon Foundation to commemorate National Cancer Act in a two day meeting

Jeremy Kortmansky named associate CMO for Network Medical Services at Smilow

Edward Kaftan named assistant cancer center director for translational science at Yale Cancer Center

Daniel E. Spratt named chair of radiation oncology at University Hospitals Seidman Cancer Center

Ute Dugan named SVP of clinical research at Parker Institute for Cancer Immunotherapy

Paul Han named senior scientist of NCI's Behavioral Research Program

Carl June, Steven Rosenberg, Zelig Eshhar named 2021 Dan David Prize Laureates

UCLA Health receives $29 million to establish center in precision genomic medicine

Broad Institute, Dana-Farber, and Count Me In receive $16 million to launch patient-partnered research initiatives in rare cancers

Biden administration: Work requirements in Medicaid do not promote the objectives of the program

George Mason, Rutgers Cancer Institute collaboration receives $1.33M U.S. Army's Breakthrough Award

Clinical Roundup

NCCN guidelines analyze evidence for nephroblastoma

Study: Cabozantinib found to be most effective treatment for metastatic papillary kidney cancer

Gene-based blood test for melanoma spread evaluates treatment progress

JNCCN study: Weight loss associated with worse outcomes in people with HER2+ early breast cancer

Single-dose radiation therapy for breast cancer removes treatment barriers for Black women

Yale study: Targeted therapy improves survival in advanced bladder cancer

Drugs & Targets

FDA approves Cosela to reduce bone marrow suppression caused by chemotherapy

Exact Sciences to acquire Ashion Analytics, enter research collaboration with City of Hope's Genomics Institute, TGen

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 50 | Issue 44 - November 22, 2024